P

harmacy benefit managers are finding themselves in the spotlight more than they used to — and their top lobbyist doesn’t mind.

PBMs and the lobbyists who advocate for them, unsurprisingly, see things differently from Congressman Doug Collins of Georgia, a Republican who last week excoriated PBMs in an interview with STAT. STAT also spoke with Mark Merritt, the CEO of the Pharmaceutical Care Management Organization, about how PBMs view their work.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.